Artiva Biotherapeutics (ARTV) Depreciation and Depletion (2023 - 2026)
Artiva Biotherapeutics' Depreciation and Depletion was $700,000 in Q2 2026, up 16.7% from $600,000 a year earlier and up 16.7% from the prior quarter.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Depreciation and Depletion (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Artiva Biotherapeutics' Depreciation and Depletion was $2.5 million through Jun 30, 2026, up 4.2% year-over-year; for FY2025, it was $2.5 million, up 4.2% from FY2024.
- In earlier years, Depreciation and Depletion was $2.4 million in FY2024 (+4.3%) and $2.3 million in FY2023.
- The Q2 2026 figure marks the highest quarterly Depreciation and Depletion in data going back to Q2 2023.
- Compared with a year earlier, Depreciation and Depletion was higher in 1 of the last eight quarters, with growth averaging 2.1%.
- The year-over-year growth in Depreciation and Depletion has ranged between 0.0% (Q3 2024) and 20.0% (Q2 2024) over the last five years.
- Per Business Quant data, ARTV's Depreciation and Depletion in the three quarters before Q2 2026 was $600,000 (Q1 2026), $600,000 (Q4 2025) and $600,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Artiva Biotherapeutics | 269.19 Mn | 269.19 Mn | - | 700,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 700,000.00 |
| Mar 31, 2026 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 600,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 500,000.00 |
API Access
Artiva Biotherapeutics Depreciation and Depletion API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ARTV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-depletion", "ticker": "ARTV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ARTV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();